Mathematical Analysis of COVID-19 Transmission Dynamics with a Case Study of Nigeria and its Computer Simulation

B. C. Agbata; Ogala Emmanuel; Tenuche Bashir; Obeng-Denteh William

doi:10.1101/2020.10.20.20216473

Abstract

In this article, we formulated a mathematical model for the spread of the COVID-19 disease and we introduced quarantined and isolated compartments. The next generation matrix method was adopted to compute the basic reproduction number (R₀) in order to assess the transmission dynamics of the COVID-19 deadly disease. Stability analysis of the disease free equilibrium is investigated based on the basic reproduction number and the result shows that it is locally and asymptotically stable for R₀ less than 1. Numerical calculation of the basic reproduction number revealed that R₀ < 1 which means that the disease can be eradicated from Nigeria. The study shows that isolation, quarantine and other government policies like social distancing and lockdown are the best approaches to control the pernicious nature of COVID-19 pandemic.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

6633482

Funding Statement

We didn't get funding from any source

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The article was submitted to Haudawi journal of Mathematics

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes